Skip to content

Flunixin

Drug profile

Also known as: flunixin meglumine, SCH-14714

FDA approved

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Flunixin is a drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including HDAC6 and DHODH.

  • Molecular targets: HDAC6 and DHODH (2 listed in DrugCentral).
  • Molecular formula: C14H11F3N2O2; molecular weight 296.25 g/mol.

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Histone deacetylase 6HDAC6unknownIC50 6.10
Dihydroorotate dehydrogenase (quinone), mitochondrialDHODHunknownIC50 5.10

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
—FDA——

Chemical structure

Molecular formulaC14H11F3N2O2
Molecular weight296.25 g/mol
CAS number38677-85-9
InChIKeyNOOCSNJCXJYGPE-UHFFFAOYSA-N
PubChem CID38081
CC1=C(NC2=C(C=CC=N2)C(O)=O)C=CC=C1C(F)(F)F

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Flunixin work?

Its molecular targets in DrugCentral include HDAC6 and DHODH.

What is the chemical formula of Flunixin?

Flunixin has the molecular formula C14H11F3N2O2 and a molecular weight of 296.25 g/mol.

Browse: all drugs starting with F · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
AgencyFDA
Targets2
Indications0
FormulaC14H11F3N2O2
DrugCentral ID5545
Interactive profile